title: Multiple mucin depleted foci, high proliferation and low apoptotic response in the onset of colon carcinogenesis of the PIRC rat, mutated in Apc.
abstract: PIRC rats (F344/NTac-Apc (am1137) ) mutated in the Apc gene spontaneously develop colon tumors thus mimicking familial adenomatous polyposis (FAP) and sporadic colorectal cancer (CRC) more closely than Apc-based rodent models developing tumors mostly in the small intestine. To understand whether microscopic dysplastic lesions precede the development of macroscopic tumors, PIRC rat colon was examined for the presence of mucin depleted foci (MDF), microadenomas of the rodent and human colon. Few MDF (about 4/animal) were already present in 1-month-old rats and their number rapidly increases to about 250 in 8-month-old rats. These lesions showed Wnt signaling activation (nuclear β-catenin accumulation) and were dramatically decreased by sulindac (320 ppm), a drug with chemopreventive activity (MDF/rat at 4 months: 156 ± 8 and 38 ± 6 in controls and sulindac-treated rats, respectively, means ± SE, p < 0.001). Since altered proliferation and apoptosis could underlie the early phases of carcinogenesis, we studied these processes in the apparently normal colon mucosa (NM) of 1-month-old PIRC and wt rats. Colon proliferation (PCNA expression) was significantly higher in PIRC rats. Notably, PIRC rat NM showed resistance to apoptosis since it sustained proliferation and had lower apoptosis after a cytotoxic insult with 1,2 dimethylhydrazine. Gene expression of Myc, p21, Birc5, Ogg1, Apex1 and Sod2 were significantly up-regulated in the NM of PIRC rat. The overall results put forward PIRC rat as useful model of colon carcinogenesis, either to study the process itself or to test in vivo chemopreventive agents in both short- and long-term studies.
authors.affiliation: Section of Pharmacology and Toxicology, NEUROFARBA Department, University of Florence, 6 Viale Pieraccini, 50139, Florence, Italy.
authors.forename: Angelo Pietro
authors.initials: AP
authors.lastname: Femia
authors.forename: Cristina
authors.initials: C
authors.lastname: Luceri
authors.forename: Paulo Victoria
authors.initials: PV
authors.lastname: Soares
authors.forename: Maura
authors.initials: M
authors.lastname: Lodovici
authors.forename: Giovanna
authors.initials: G
authors.lastname: Caderni
mesh_terms: D000818:Animals; D017209:Apoptosis; D049109:Cell Proliferation; D003106:Colon / Q000473:pathology; D003110:Colonic Neoplasms / Q000209:etiology* / Q000473:pathology; D003111:Colonic Polyps / Q000473:pathology*; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000502:physiology; D005260:Female; D017491:Genes, APC; D016259:Genes, myc; D008297:Male; D008869:Microtubule-Associated Proteins / Q000502:physiology; D009077:Mucins / Q000502:physiology*; D009154:Mutation; D051381:Rats; D011916:Rats, Inbred F344; D013467:Sulindac / Q000494:pharmacology; D000077022:Survivin
chemical_list: C516989:Birc5 protein, rat; D050759:Cyclin-Dependent Kinase Inhibitor p21; D008869:Microtubule-Associated Proteins; D009077:Mucins; D000077022:Survivin; D013467:Sulindac
keywords: Apc; PIRC rat; colon carcinogenesis; mucin depleted foci